The global Cell Line and Membrane Market size reached US$ 4.5 billion in 2021 and it is projected to reach US$ 10.6 billion by 2031, exhibiting a CAGR of 8.8% during 2021-2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Allied Market Research published a report, titled, “Cell Line and Membrane Market by Products (Media and Reagents, Equipments, Accessories and Consumables), by Source (Non Mammalian Cell Line, Mammalian Cell Line), by Type (Recombinant cell lines, Primary cell lines, Hybridomas, Continuous cell lines), by End User (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.”
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/14227
Key Players of Global Cell Line and Membrane Market Report–
- Advanced Instruments LLC
- AGC Biologics
- Cytiva Lifesciences
- Sartorius Cellgenix Gmbh
- Premas Biotech
- Selexis SA
- Samsung Biologics
- Thermofisher Scientific Inc.
- Imegenex IndiaPvt. Ltd.
Global Cell Line and Membrane Market Segmentation: –
Based on products, the media and reagents segment contributed to the largest share of more than half of the global cell line and membrane market in 2021, and is expected to rule the roost during the forecast period. Moreover, the same segment is projected to witness the fastest CAGR of 9.2% from 2021 to 2031. The growth of this segment is attributed to rise in the prevalence of cancer and chronic diseases, rise in number of R&D activities globally, and increasing product approval and new product launches.
Based on source, the mammalian cell line segment held the largest share of more than two-thirds of the global cell line and membrane market in 2021, and is expected to maintain a prominent growth during the forecast period. The dominance of this segment can be attributed to the rise in the demand for recombinant protein development through mammalian cell. However, the non-mammalian cell line segment is likely to exhibit the highest CAGR of 9.8% in 2031, owing to the increase in adoption of regenerative medicines, rise in prevalence of cancer across the globe, and surge in investments in R&D by pharmaceutical and biotechnology companies.
Based on type, the recombinant cell lines segment was the largest market in 2021, accounting for more than one-third of the global cell line and membrane market, and is likely to lead the trail throughout the forecast period. This is due to the rise in the demand for recombinant cell line which owes greatly to technological advancements in expression vector design, cell line engineering, and clone screening. However, the primary cell lines segment is anticipated to manifest the fastest CAGR of 10.1% during the forecast period, owing to rise in adoption of primary cell line for the production and manufacturing of bio-therapeutics such as vaccines, monoclonal antibodies, and fusion proteins.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/14227
Based on region, North America was the largest market in 2021, accounting for around two-fifths of the global cell line and membrane market, and is likely to lead the trail throughout the forecast period. This is due to the increase in the healthcare expenditure, a rise in the prevalence of cancer, growing demand for cell line for the development of therapeutic monoclonal antibodies and novel antibodies, and the presence of major players in this region.
However, Asia-Pacific is anticipated to manifest the fastest CAGR of 9.8% during the forecast period, due to the rise in prevalence of chronic diseases, an increase in the geriatric population and an emerging economy in the region.
Drivers and Opportunities
Rise in the prevalence of cancer and chronic diseases, increase in the geriatric population, growth in the adoption of regenerative medicines, a surge in investments in R&D by pharmaceutical and biotechnology companies, rise in development & demand for monoclonal antibodies, increase in production of vaccines, and technological innovations in cell lines and the membrane fuel the growth of the global cell line and membrane market. However, a strict regulatory framework coupled with the time-consuming process for the development of stable lines might hinder the market growth. On the other hand, low-income countries lacking access to basic healthcare and an increase in the risk of pandemic and communicable diseases present new opportunities in the market in the coming years.
By Region Outlook
- North America
(U.S., Canada, Mexico)
(Germany, France, UK, Italy, Spain, Rest of Europe)
(Japan, China, India, Rest of Asia-Pacific)
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/connect-to-analyst/14227
Other Top Trending Reports:-
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060